• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻素的作用机制及其在皮肤病中的潜在应用。

Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases.

机构信息

University of Toronto, Toronto, Canada.

The Hospital for Sick Children and University of Toronto, 555 University Ave, Toronto, ON, M5G 1X8, Canada.

出版信息

Clin Drug Investig. 2020 Apr;40(4):293-304. doi: 10.1007/s40261-020-00894-7.

DOI:10.1007/s40261-020-00894-7
PMID:32060787
Abstract

The legalisation of cannabis in a growing number of jurisdictions has led to increasing interest in its potential therapeutic effects in a range of disorders, including cutaneous conditions. Cannabinoids have been used as natural medicines for centuries; however, their biological activity in the skin is a new area of study. Recent data suggest that cannabinoids are involved in neuro-immuno-endocrine modulation of skin functioning, yet their effect on the features of dermatologic conditions is unclear. This article sought to review the mechanisms by which cannabinoids regulate skin functioning through the lens of relevance to treatment of dermatologic diseases looking at the effects of cannabinoids on a range of cellular activities and dermatologic conditions both in vitro and in vivo. We identified studies demonstrating an inhibitory effect of cannabinoids on skin inflammation, proliferation, fibrosis, pain, and itch-biological mechanisms involved in the pathogenesis of many dermatologic conditions. Cannabinoids have the potential to expand the therapeutic repertoire of a wide spectrum of skin disorders. Given their widespread unregulated use by the general public, basic and clinical studies are required to elucidate the effectiveness and long-term effects of topical and systemic cannabinoids in cutaneous disorders.

摘要

大麻在越来越多的司法管辖区合法化,导致人们对其在一系列疾病(包括皮肤疾病)中的潜在治疗作用越来越感兴趣。大麻素作为天然药物已经使用了几个世纪;然而,它们在皮肤中的生物活性是一个新的研究领域。最近的数据表明,大麻素参与皮肤功能的神经免疫内分泌调节,但它们对皮肤疾病特征的影响尚不清楚。本文试图通过研究大麻素对各种细胞活动和皮肤疾病的影响,从治疗皮肤病的角度来探讨大麻素调节皮肤功能的机制,着眼于大麻素对这些疾病的作用。我们发现了一些研究表明,大麻素对皮肤炎症、增殖、纤维化、疼痛和瘙痒具有抑制作用,这些生物学机制涉及许多皮肤病的发病机制。大麻素有可能扩大广泛的皮肤疾病的治疗范围。鉴于大麻素在普通民众中广泛不受监管地使用,需要进行基础和临床研究,以阐明局部和全身使用大麻素在皮肤疾病中的有效性和长期效果。

相似文献

1
Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases.大麻素的作用机制及其在皮肤病中的潜在应用。
Clin Drug Investig. 2020 Apr;40(4):293-304. doi: 10.1007/s40261-020-00894-7.
2
Cannabinoids in dermatology: a scoping review.皮肤病学中的大麻素:一项范围综述
Dermatol Online J. 2018 Jun 15;24(6):13030/qt7pn8c0sb.
3
Cannabinoids for the treatment of autoimmune and inflammatory skin diseases: A systematic review.大麻素治疗自身免疫性和炎症性皮肤病:系统评价。
Exp Dermatol. 2024 Mar;33(3):e15064. doi: 10.1111/exd.15064.
4
Cannabinoids in the Pathophysiology of Skin Inflammation.大麻素在皮肤炎症发病机制中的作用。
Molecules. 2020 Feb 4;25(3):652. doi: 10.3390/molecules25030652.
5
Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases.大麻素化合物作为治疗非癌症皮肤疾病的一种药物治疗选择。
Cells. 2022 Dec 16;11(24):4102. doi: 10.3390/cells11244102.
6
Cannabinoid system in the skin - a possible target for future therapies in dermatology.皮肤中的大麻素系统——皮肤病未来治疗的一个可能靶点。
Exp Dermatol. 2009 Aug;18(8):669-79. doi: 10.1111/j.1600-0625.2009.00923.x.
7
Cannabinoids: Potential Role in Inflammatory and Neoplastic Skin Diseases.大麻素:在炎症性和肿瘤性皮肤病中的潜在作用。
Am J Clin Dermatol. 2019 Apr;20(2):167-180. doi: 10.1007/s40257-018-0410-5.
8
Cannabinoids in the treatment of rheumatic diseases: Pros and cons.大麻素类药物治疗风湿性疾病:利弊。
Autoimmun Rev. 2019 Dec;18(12):102409. doi: 10.1016/j.autrev.2019.102409. Epub 2019 Oct 21.
9
Topical cannabinoids in dermatology.皮肤科中的局部用大麻素类药物。
Cutis. 2017 Jul;100(1):50-52.
10
The role of cannabinoids in dermatology.大麻素在皮肤病学中的作用。
J Am Acad Dermatol. 2017 Jul;77(1):188-190. doi: 10.1016/j.jaad.2017.02.056. Epub 2017 Apr 14.

引用本文的文献

1
β-Caryophyllene Ameliorates Thioacetamide-Induced Liver Fibrosis in Rats: A Preventative Approach.β-石竹烯改善硫代乙酰胺诱导的大鼠肝纤维化:一种预防性方法。
Int J Mol Sci. 2025 Sep 1;26(17):8493. doi: 10.3390/ijms26178493.
2
Evaluation of Biophysical Parameters of the Skin of Patients With Atopic Dermatitis After Application of an Ointment Containing 30% Cannabidiol and 5% Cannabigerol.对患有特应性皮炎的患者在涂抹含有30%大麻二酚和5%大麻萜酚的药膏后皮肤生物物理参数的评估。
Clin Cosmet Investig Dermatol. 2025 Mar 19;18:649-662. doi: 10.2147/CCID.S472746. eCollection 2025.
3
Editorial: Therapeutic potential of cannabinoids: from health to disease.

本文引用的文献

1
Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1.大麻二酚通过靶向 BACH1 诱导角质形成细胞中的抗氧化途径。
Redox Biol. 2020 Jan;28:101321. doi: 10.1016/j.redox.2019.101321. Epub 2019 Sep 5.
2
Cannabinoids: Potential Role in Inflammatory and Neoplastic Skin Diseases.大麻素:在炎症性和肿瘤性皮肤病中的潜在作用。
Am J Clin Dermatol. 2019 Apr;20(2):167-180. doi: 10.1007/s40257-018-0410-5.
3
New approaches and challenges to targeting the endocannabinoid system.靶向内源性大麻素系统的新方法与挑战
社论:大麻素的治疗潜力:从健康到疾病
Front Neurosci. 2025 Feb 19;19:1565790. doi: 10.3389/fnins.2025.1565790. eCollection 2025.
4
Therapeutic potential and pharmacological insights of total glucosides of paeony in dermatologic diseases: a comprehensive review.芍药总苷在皮肤病中的治疗潜力和药理学见解:综述
Front Pharmacol. 2025 Jan 2;15:1423717. doi: 10.3389/fphar.2024.1423717. eCollection 2024.
5
Therapeutic potential of agents targeting cannabinoid type 2 receptors in organ fibrosis.靶向大麻素受体 2 的药物在器官纤维化中的治疗潜力。
Pharmacol Res Perspect. 2024 Dec;12(6):e1219. doi: 10.1002/prp2.1219.
6
Overview of popular cosmeceuticals in dermatology.皮肤科常用药妆概述。
Skin Health Dis. 2024 Feb 7;4(2):e340. doi: 10.1002/ski2.340. eCollection 2024 Apr.
7
Therapeutic Potential of Minor Cannabinoids in Dermatological Diseases-A Synthetic Review.治疗皮肤疾病中小分子大麻素的潜力——综述
Molecules. 2023 Aug 20;28(16):6149. doi: 10.3390/molecules28166149.
8
Phytocannabinoids in the Pharmacotherapy of Psoriasis.植物大麻素在银屑病治疗中的应用。
Molecules. 2023 Jan 25;28(3):1192. doi: 10.3390/molecules28031192.
9
8,9-Dihydrocannabidiol, an Alternative of Cannabidiol, Its Preparation, Antibacterial and Antioxidant Ability.8,9-二氢大麻二酚,一种大麻二酚的替代品,其制备方法、抗菌和抗氧化能力。
Molecules. 2023 Jan 3;28(1):445. doi: 10.3390/molecules28010445.
10
Medical cannabis dimethyl ether, ethanol and butane extracts inhibit the growth of bacteria and dermatophytes causing common skin diseases.医用大麻二甲醚、乙醇和丁烷提取物可抑制引起常见皮肤病的细菌和皮肤真菌的生长。
Front Microbiol. 2022 Sep 20;13:953092. doi: 10.3389/fmicb.2022.953092. eCollection 2022.
Nat Rev Drug Discov. 2018 Sep;17(9):623-639. doi: 10.1038/nrd.2018.115. Epub 2018 Aug 17.
4
Dangerous plants in dermatology: Legal and controlled.皮肤科中的危险植物:合法且受管控。
Clin Dermatol. 2018 May-Jun;36(3):399-419. doi: 10.1016/j.clindermatol.2018.03.013. Epub 2018 Mar 29.
5
Self-initiated use of topical cannabidiol oil for epidermolysis bullosa.表皮松解性大疱病患者自行使用局部大麻二酚油剂的情况。
Pediatr Dermatol. 2018 Jul;35(4):e224-e227. doi: 10.1111/pde.13545. Epub 2018 May 22.
6
Targeting Cannabinoid Signaling in the Immune System: "High"-ly Exciting Questions, Possibilities, and Challenges.靶向免疫系统中的大麻素信号传导:“高度”令人兴奋的问题、可能性与挑战
Front Immunol. 2017 Nov 10;8:1487. doi: 10.3389/fimmu.2017.01487. eCollection 2017.
7
Endocannabinoids and Immunity.内源性大麻素与免疫
Cannabis Cannabinoid Res. 2016 Feb 1;1(1):59-66. doi: 10.1089/can.2016.0002. eCollection 2016.
8
The trajectories of cannabis and tobacco policies in the United States, Uruguay, Canada and Portugal: is more cross-substance learning possible outside the United States?美国、乌拉圭、加拿大和葡萄牙的大麻与烟草政策轨迹:在美国以外地区是否有更多跨物质政策借鉴的可能?
Addiction. 2018 Apr;113(4):603-605. doi: 10.1111/add.13954. Epub 2017 Aug 23.
9
Cannabinoid Reduces Inflammatory Cytokines, Tumor Necrosis Factor-α, and Type I Interferons in Dermatomyositis In Vitro.大麻素在体外可降低皮肌炎中的炎性细胞因子、肿瘤坏死因子-α和I型干扰素水平。
J Invest Dermatol. 2017 Nov;137(11):2445-2447. doi: 10.1016/j.jid.2017.05.035. Epub 2017 Jun 23.
10
The role of cannabinoids in dermatology.大麻素在皮肤病学中的作用。
J Am Acad Dermatol. 2017 Jul;77(1):188-190. doi: 10.1016/j.jaad.2017.02.056. Epub 2017 Apr 14.